Abstract
Alcohol consumption is a major risk factor for the acquisition of HIV/AIDS and is associated with greater disease burden and mortality among those who become HIV-infected. Of the extant pharmacological treatments for alcohol use disorders, naltrexone is recognized as one of the most efficacious, producing robust reductions in alcohol craving and use. Given that treatment with oral naltrexone has been limited by problems with adherence, which are particularly prevalent among individuals with multiple chronic, co-occurring conditions, long-acting formulations may be a promising approach for HIV-infected substance users. However, little is known about the barriers to initiation of extended-release naltrexone (XR-NTX) treatment among alcohol users living with HIV. In this report we present and discuss the content analysis of open-ended survey questions, as well as lessons learned, with regards to barriers to initiation and maintenance of XR-NTX treatment collected as part of an RCT evaluating a cognitive behavioral text messaging intervention for HIV-infected adults with alcohol use disorders. Barriers to initiation and maintenance of XR-NTX pharmacotherapy among HIV+ individuals with alcohol use disorders seem to fall in one of tw...Continue Reading
References
Nov 1, 1992·Archives of General Psychiatry·J R VolpicelliC P O'Brien
Feb 28, 2002·Psychopharmacology·Stephanie S O'MalleyMary Jeanne Kreek
Aug 31, 2002·Addictive Behaviors·Michael D SteinPeter D Friedmanna
Jun 27, 2003·The New England Journal of Medicine·Elizabeth A McGlynnEve A Kerr
Sep 2, 2004·Journal of Addictive Diseases·Katherine M Harris, Cindy Thomas
Apr 1, 2006·Journal of Leukocyte Biology·Xu WangWen-Zhe Ho
Feb 1, 2007·Prevention Science : the Official Journal of the Society for Prevention Research·Seth C KalichmanSean Jooste
Nov 27, 2008·Addiction·Henry R KranzlerDavid R Gastfriend
Oct 8, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Perrine RouxBruno Spire
Dec 2, 2009·International Journal of Public Health·Dolly BaliunasPaul Shuper
Jan 12, 2010·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Paul A ShuperJürgen Rehm
Mar 6, 2010·CNS & Neurological Disorders Drug Targets·Lara A RayKaren Miotto
Mar 25, 2010·Addiction·Sasha UhlmannEvan Wood
Apr 23, 2010·Journal of Studies on Alcohol and Drugs·Amanda J Abraham, Paul M Roman
Aug 31, 2010·Current HIV/AIDS Reports·David S Metzger, Yan Zhang
Dec 14, 2011·Addiction·Jürgen RehmPaul A Shuper
Apr 13, 2013·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Peter D FriedmannThomas P O'Toole
May 16, 2014·JAMA : the Journal of the American Medical Association·Daniel E JonasJames C Garbutt
Nov 13, 2015·Drug and Alcohol Dependence·Sandra A SpringerFrederick L Altice
Dec 15, 2015·Journal of Substance Abuse Treatment·Kelly Alanis-HirschDennis McCarty
Feb 10, 2016·Drug and Alcohol Dependence·Geetanjali ChanderMary E McCaul
Jun 28, 2016·JMIR Research Protocols·Suzette Glasner-EdwardsAlexandra Venegas
Jul 13, 2016·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Amy W HelstromDavid Oslin
Citations
Aug 4, 2018·AIDS and Behavior·E Jennifer EdelmanLynn E Fiellin
May 22, 2019·The Lancet. HIV·E Jennifer EdelmanDavid A Fiellin
Jun 24, 2020·Peptides·Richard J Bodnar
May 28, 2021·Patient Preference and Adherence·Virginia Perez-MaciaLorena Garcia-Fernandez
Aug 28, 2021·International Journal of Environmental Research and Public Health·Fares QeadanKevin English